Blue Sail (China) Performance
002382 Stock | 5.56 0.06 1.09% |
On a scale of 0 to 100, Blue Sail holds a performance score of 12. The firm shows a Beta (market volatility) of -0.35, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Blue Sail are expected to decrease at a much lower rate. During the bear market, Blue Sail is likely to outperform the market. Please check Blue Sail's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Blue Sail's price patterns will revert.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Blue Sail Medical are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Blue Sail sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 20:10 | Ex Dividend Date 2023-05-31 | Last Split Date 2016-05-17 |
1 | There May Be Underlying Issues With The Quality Of Intco Medical Technologys Earnings - Simply Wall St | 11/04/2024 |
Begin Period Cash Flow | 1.9 B |
Blue |
Blue Sail Relative Risk vs. Return Landscape
If you would invest 450.00 in Blue Sail Medical on August 30, 2024 and sell it today you would earn a total of 106.00 from holding Blue Sail Medical or generate 23.56% return on investment over 90 days. Blue Sail Medical is generating 0.3974% of daily returns and assumes 2.5615% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than Blue, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Blue Sail Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Blue Sail's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Blue Sail Medical, and traders can use it to determine the average amount a Blue Sail's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1551
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | 002382 | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.56 actual daily | 22 78% of assets are more volatile |
Expected Return
0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Blue Sail is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Blue Sail by adding it to a well-diversified portfolio.
Blue Sail Fundamentals Growth
Blue Stock prices reflect investors' perceptions of the future prospects and financial health of Blue Sail, and Blue Sail fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Blue Stock performance.
Return On Equity | -0.0442 | ||||
Return On Asset | -0.0129 | ||||
Profit Margin | (0.07) % | ||||
Operating Margin | 0.02 % | ||||
Current Valuation | 6.99 B | ||||
Shares Outstanding | 1.01 B | ||||
Price To Book | 0.63 X | ||||
Price To Sales | 0.93 X | ||||
Revenue | 4.93 B | ||||
Gross Profit | 419.17 M | ||||
EBITDA | 198.28 M | ||||
Net Income | (568.36 M) | ||||
Total Debt | 3.86 B | ||||
Book Value Per Share | 8.82 X | ||||
Cash Flow From Operations | (72.89 M) | ||||
Earnings Per Share | (0.44) X | ||||
Total Asset | 15.63 B | ||||
Retained Earnings | 2.12 B | ||||
About Blue Sail Performance
By analyzing Blue Sail's fundamental ratios, stakeholders can gain valuable insights into Blue Sail's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Blue Sail has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Blue Sail has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Blue Sail is entity of China. It is traded as Stock on SHE exchange.Things to note about Blue Sail Medical performance evaluation
Checking the ongoing alerts about Blue Sail for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Blue Sail Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.The company reported the revenue of 4.93 B. Net Loss for the year was (568.36 M) with profit before overhead, payroll, taxes, and interest of 419.17 M. | |
Blue Sail generates negative cash flow from operations | |
About 33.0% of the company shares are owned by insiders or employees | |
Latest headline from news.google.com: There May Be Underlying Issues With The Quality Of Intco Medical Technologys Earnings - Simply Wall St |
- Analyzing Blue Sail's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Blue Sail's stock is overvalued or undervalued compared to its peers.
- Examining Blue Sail's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Blue Sail's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Blue Sail's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Blue Sail's stock. These opinions can provide insight into Blue Sail's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Blue Stock analysis
When running Blue Sail's price analysis, check to measure Blue Sail's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Blue Sail is operating at the current time. Most of Blue Sail's value examination focuses on studying past and present price action to predict the probability of Blue Sail's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Blue Sail's price. Additionally, you may evaluate how the addition of Blue Sail to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Global Correlations Find global opportunities by holding instruments from different markets |